EuroPCR 2025 | BALI Trial: Intravascular Lithotripsy vs. Conventional Lesion Preparation in Calcified Lesions

Severely calcified coronary lesions represent a therapeutic challenge and have been associated with higher rates of failed percutaneous coronary intervention (PCI), and a negative impact on long-term outcomes. In this context, researchers evaluated whether intravascular lithotripsy (IVL) is superior to conventional lesion preparation prior stenting.

200 patients with angiographically severe calcification were included, and were randomized to either IVL or conventional preparation. All patients underwent optical coherence tomography (OCT), and rotational atherectomy was allowed if predefined criteria were met.

The primary endpoint included procedural failure (defined as non-viable stenting or ≥20% residual stenosis on OCT) and target vessel failure (TVF), which included acute MI, clinically driven revascularization, or cardiac death.

The conventional strategy involved non-compliant balloons (82%), cutting/scoring balloons (57%), and ultra-high-pressure balloons (3%). Rotational atherectomy was used in 31% of IVL patients and 42% of conventional patients.

Results showed a primary endpoint incidence of 35.4% in the IVL group vs. 51.5% in the conventional preparation group (RR 0.69; 95% CI 0.48–0.97; p=0.02).

Read also: EuroPCR 2025 | Multivessel PCI in Cardiogenic Shock: A Substudy from the DanGer Shock.

As regards periprocedural complications, no significant differences were observed in AMI rate, flow-limiting dissections, or perforations.

The authors concluded that in severely calcified lesions, IVL reduced the incidence of procedural failure or TVF at one year with no increase of procedure-related adverse events.

Presented by A. T. Kristensen during the Major Late Breaking Trials session, EuroPCR 2025, May 21, Paris, France.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...